Relmada Therapeutics, Inc. RLMD
Set alert
3.58 USD +0.14 +4.07%
At close · Oct 30
3.50 -0.08 -2.23%
After hours · Oct 30, 4:13 PM ET
3.31 Day range 3.66
2.20 52-week range 7.86
- YTD
- -25.88%
- 1 year
- +54.31%
- Open
- 3.42
- Prev close
- 3.44
- Mkt cap
- 381.88M
- Vol
- 1.41M
- Avg vol
- 1.33M
- EPS
- -0.91
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 3.31
- High
- 3.66
- Forward P/E
- -0.19
- Beta
- 0.41
- Short ratio
- 4.52
- Inst. own
- 46.06%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 2.53
- 200-d avg
- 3.33
- 1y target
- 0.86667
5D chart
Signals (63)
| Name | Time | Ago |
|---|---|---|
| RSI: Overbought | Oct 30, 10:55 AM | 1 day ago |
| MACD: Buy Signal | Oct 30, 10:25 AM | 1 day ago |
| SMA: Bullish | Oct 30, 10:15 AM | 1 day ago |
| RSI: Oversold | Oct 30, 9:45 AM | 1 day ago |
| SMA: Bearish | Oct 30, 9:30 AM | 1 day ago |
| MACD: Sell Signal | Oct 29, 3:50 PM | 2 days ago |
| MACD: Buy Signal | Oct 29, 2:40 PM | 2 days ago |
| SMA: Bullish | Oct 29, 2:25 PM | 2 days ago |
| MACD: Sell Signal | Oct 29, 2:00 PM | 2 days ago |
| SMA: Bearish | Oct 29, 1:55 PM | 2 days ago |
| SMA: Bearish | Oct 29, 1:55 PM | 2 days ago |
| MACD: Buy Signal | Oct 29, 1:05 PM | 2 days ago |
| SMA: Bullish | Oct 29, 12:55 PM | 2 days ago |
| SMA: Bullish | Oct 29, 12:50 PM | 2 days ago |
| MACD: Sell Signal | Oct 29, 11:50 AM | 2 days ago |
| RSI: Overbought | Oct 29, 11:30 AM | 2 days ago |
| RSI: Overbought | Oct 29, 11:20 AM | 2 days ago |
| MACD: Buy Signal | Oct 29, 11:10 AM | 2 days ago |
| MACD: Sell Signal | Oct 29, 10:40 AM | 2 days ago |
| SMA: Bearish | Oct 29, 10:30 AM | 2 days ago |
| SMA: Bullish | Oct 29, 9:45 AM | 2 days ago |
| SMA: Bearish | Oct 29, 9:40 AM | 2 days ago |
| SMA: Bullish | Oct 29, 9:35 AM | 2 days ago |
| SMA: Bullish | Oct 29, 9:35 AM | 2 days ago |
| SMA: Bearish | Oct 29, 9:30 AM | 2 days ago |
| SMA: Bearish | Oct 29, 9:30 AM | 2 days ago |
| RSI: Overbought | Oct 28, 3:50 PM | 3 days ago |
| MACD: Buy Signal | Oct 28, 3:35 PM | 3 days ago |
| MACD: Sell Signal | Oct 28, 1:50 PM | 3 days ago |
| SMA: Bearish | Oct 28, 1:40 PM | 3 days ago |
| RSI: Overbought | Oct 28, 12:55 PM | 3 days ago |
| MACD: Buy Signal | Oct 28, 12:40 PM | 3 days ago |
| SMA: Bullish | Oct 28, 12:30 PM | 3 days ago |
| SMA: Bullish | Oct 28, 11:05 AM | 3 days ago |
| MACD: Sell Signal | Oct 28, 10:35 AM | 3 days ago |
| RSI: Overbought | Oct 28, 9:55 AM | 3 days ago |
| SMA: Bullish | Oct 27, 3:55 PM | 4 days ago |
| SMA: Bearish | Oct 27, 3:15 PM | 4 days ago |
| MACD: Buy Signal | Oct 27, 3:00 PM | 4 days ago |
| RSI: Oversold | Oct 27, 2:20 PM | 4 days ago |
| RSI: Oversold | Oct 27, 1:55 PM | 4 days ago |
| SMA: Bearish | Oct 27, 1:50 PM | 4 days ago |
| MACD: Sell Signal | Oct 27, 1:40 PM | 4 days ago |
| MACD: Buy Signal | Oct 27, 1:15 PM | 4 days ago |
| SMA: Bearish | Oct 27, 12:35 PM | 4 days ago |
| MACD: Sell Signal | Oct 27, 12:35 PM | 4 days ago |
| MACD: Buy Signal | Oct 27, 12:00 PM | 4 days ago |
| SMA: Bullish | Oct 27, 11:55 AM | 4 days ago |
| SMA: Bullish | Oct 27, 11:55 AM | 4 days ago |
| SMA: Bearish | Oct 27, 11:40 AM | 4 days ago |
| SMA: Bullish | Oct 27, 11:35 AM | 4 days ago |
| MACD: Sell Signal | Oct 27, 11:20 AM | 4 days ago |
| SMA: Bearish | Oct 27, 11:00 AM | 4 days ago |
| RSI: Overbought | Oct 27, 10:45 AM | 4 days ago |
| SMA: Bullish | Oct 27, 10:15 AM | 4 days ago |
| SMA: Bullish | Oct 27, 10:05 AM | 4 days ago |
| MACD: Buy Signal | Oct 27, 10:05 AM | 4 days ago |
| MACD: Sell Signal | Oct 27, 9:30 AM | 4 days ago |
| SMA: Bearish | Oct 26, 3:55 PM | 5 days ago |
| MACD: Buy Signal | Oct 26, 3:35 PM | 5 days ago |
| MACD: Sell Signal | Oct 26, 12:55 PM | 5 days ago |
| SMA: Bullish | Oct 26, 11:10 AM | 5 days ago |
| SMA: Bearish | Oct 26, 10:30 AM | 5 days ago |
Financial health
Altman Z-Score
13.25 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C-1 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 2
Valuation
P/E -3.3×
FY 2016 5y median -0.3× FY 2025
P/S 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 2.2×
FY 2016 5y median 0.4× FY 2025
P/FCF -4.2×
FY 2016 5y median -0.6× FY 2025
EV/EBITDA -3.3×
FY 2016 5y median -0.1× FY 2025
EV/Sales 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -24.0%
FY 2016 5y median -166.6% FY 2025
Profitability
Gross Margin 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -66.3%
FY 2016 5y median -111.8% FY 2025
ROIC -67.5%
FY 2016 5y median -114.8% FY 2025
ROA -61.0%
FY 2016 5y median -101.3% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2016 FY 2025
Operating Income 29.6%
FY 2016 FY 2025
EPS (diluted) 45.3%
FY 2016 FY 2025
Free Cash Flow 11.5%
FY 2016 FY 2025
Financial Health
Current Ratio 14.6×
FY 2016 5y median 12.3× FY 2025
Quick Ratio 14.6×
FY 2016 5y median 12.3× FY 2025
Debt / Equity 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.1×
FY 2016 5y median 0.0× FY 2025
Interest Coverage 0.0×
FY 2016 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31